These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19446330)

  • 1. Isolated CNS lymphoid blast crisis in a patient with imatinib-resistant chronic myelogenous leukemia: case report and review of the literature.
    Aftimos P; Nasr F
    Leuk Res; 2009 Nov; 33(11):e178-80. PubMed ID: 19446330
    [No Abstract]   [Full Text] [Related]  

  • 2. Promyelocytic blast crisis of chronic myelogenous leukemia during imatinib treatment.
    Gozzetti A; Bocchia M; Calabrese S; Pirrotta MT; Crupi R; Raspadori D; Lauria F
    Acta Haematol; 2007; 117(4):236-7. PubMed ID: 17308370
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of chronic myelogenous leukemia responding to imatinib mesilate (Glivec) after relapse of blastic crisis following allogeneic bone marrow transplantation].
    Fujisawa S; Yano K; Kobayashi M
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):427-30. PubMed ID: 12669406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated blast crisis in CNS in a patient with chronic myelogenous leukemia maintaining major cytogenetic response after imatinib.
    Kim HJ; Jung CW; Kim K; Ahn JS; Kim WS; Park K; Ko YH; Kang WK; Park K
    J Clin Oncol; 2006 Aug; 24(24):4028-9. PubMed ID: 16921058
    [No Abstract]   [Full Text] [Related]  

  • 5. Imatinib-resistant lymphoid clone of chronic myelogenous leukemia in blast phase arising from B cell-committed progenitor leukemic stem cells.
    Kobayashi S; Sato K; Kobayashi A; Osawa Y; Nakamura Y; Kimura F
    Ann Hematol; 2011 Mar; 90(3):367-8. PubMed ID: 20556391
    [No Abstract]   [Full Text] [Related]  

  • 6. Promyelocytic blast crisis of chronic myeloid leukemia during imatinib treatment.
    Chung HJ; Chi HS; Cho YU; Park CJ; Seo EJ; Kim KH; Lee JH
    Ann Clin Lab Sci; 2008; 38(3):283-6. PubMed ID: 18715859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic phase of ETV6-ABL1 positive CML responds to imatinib.
    Kawamata N; Dashti A; Lu D; Miller B; Koeffler HP; Schreck R; Moore S; Ogawa S
    Genes Chromosomes Cancer; 2008 Oct; 47(10):919-21. PubMed ID: 18615681
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolated central nervous system relapse after nine years of complete molecular remission in a lymphoid blast crisis of chronic myeloid leukemia treated with imatinib.
    Breccia M; Santopietro M; Cannella L; Federico V; Loglisci G; Serrao A; Petrucci L; Salaroli A; Nanni M; De Propris MS; Diverio D; Alimena G
    Leuk Res; 2011 Jun; 35(6):e91-2. PubMed ID: 21316103
    [No Abstract]   [Full Text] [Related]  

  • 9. [Initial therapy of imatinib mesylate for extramedullary T lymphoblastic crisis of chronic myeloid leukemia: a case report and review of the literature].
    He HS; Su GP; Chen BB
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):477-8. PubMed ID: 22213870
    [No Abstract]   [Full Text] [Related]  

  • 10. Extramedullary blast crisis occurring in a Philadelphia-positive chronic myeloid leukemia patient with major cytogenetic response to imatinib.
    Breccia M; Nanni M; Mancini F; Russo E; Mecarocci S; Alimena G
    Haematologica; 2004 Apr; 89(4):ECR11. PubMed ID: 15075103
    [No Abstract]   [Full Text] [Related]  

  • 11. Imatinib resistance and progression of CML to blast crisis: somatic hypermutation AIDing the way.
    Strout MP; Schatz DG
    Cancer Cell; 2009 Sep; 16(3):174-6. PubMed ID: 19732715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biclonal blast crisis with a mutated ABL catalytic domain in a Ph, del (9q)-positive CML patient responsive to imatinib: drug resistance should be monitored in all patients irrespective of response status.
    Alimena G; Breccia M; Mancini M; Diverio D; Nanni M; De Propris MS; Cimino G; Pane F; Mandelli F
    Leukemia; 2005 Feb; 19(2):287-9. PubMed ID: 15538403
    [No Abstract]   [Full Text] [Related]  

  • 13. Survival more than 19 years after the diagnosis of accelerated phase of chronic myelocytic leukemia.
    Wiernik PH; Baig MA; Lee SH; Dutcher JP; Paietta E; Racevskis J
    Clin Adv Hematol Oncol; 2011 Mar; 9(3):242-8. PubMed ID: 21475132
    [No Abstract]   [Full Text] [Related]  

  • 14. Stem cell regulation and the development of blast crisis in chronic myeloid leukemia: Implications for the outcome of Imatinib treatment and discontinuation.
    Wodarz D
    Med Hypotheses; 2008; 70(1):128-36. PubMed ID: 17566666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated central nervous system blast crisis in chronic myeloid leukemia.
    Rajappa S; Uppin SG; Raghunadharao D; Rao IS; Surath A
    Hematol Oncol; 2004 Dec; 22(4):179-81. PubMed ID: 15995975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of lymphoid blast crisis over 20 years after successful sibling allo-SCT for CML: short lived complete cytogenetic response to imatinib.
    Irvine DA; Shepherd JD
    Bone Marrow Transplant; 2009 Aug; 44(4):267-8. PubMed ID: 19234506
    [No Abstract]   [Full Text] [Related]  

  • 17. A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment.
    Janssen JJ; Berendse HW; Schuurhuis GJ; Merle PA; Ossenkoppele GJ
    Am J Hematol; 2009 Oct; 84(10):679-82. PubMed ID: 19658186
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of imatinib in chronic myeloid leukemia in blastic crisis presenting as cholestatic jaundice.
    Ramamoorthy SK; Pandita R; Prakash A; Ramaswamy NV; Al Bahar S
    Acta Haematol; 2007; 118(3):141-5. PubMed ID: 17804901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extramedullary blastic crisis in abdominal lymph nodes in a patient with chronic myelogenous leukemia on imatinib.
    Shune L; Cayci Z; Rogosheske J; Brunstein C; Ustun C
    Leuk Res; 2012 Jun; 36(6):e131-2. PubMed ID: 22444689
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular response to imatinib in patient with Ph negative p190 BCR-ABL transcript positive chronic myeloid leukemia with cyclic leukocytosis.
    Radojkovic M; Ristic S; Pavlovic S; Colovic M
    Leuk Res; 2009 Jun; 33(6):e10-2. PubMed ID: 19091403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.